Carnegie Mellon and Yale Study in Mice Shows Promise for Treating Genetic Conditions During Early Stages of Development
Researchers at Carnegie Mellon University and Yale University have for the first time used a gene editing technique to successfully cure a genetic condition in utero in a mouse model. Their findings, published in Nature Communications, present a promising new avenue for research into treating genetic conditions during fetal development.
An estimated 8 million children are born each year with severe genetic disorders or birth defects. Genetic conditions can often be detected during pregnancy using amniocentesis, but there are no treatment options to correct these genetic conditions before birth.
“Early in embryonic development, there are a lot of stem cells dividing at a rapid pace. If we can go in and correct a genetic mutation early on, we could dramatically reduce the impact the mutation has on fetal development or even cure the condition,” said Danith Ly, professor of chemistry in Carnegie Mellon’s Mellon College of Science.
In this study, the researchers used a peptide nucleic acid-based gene editing technique that they had previously used to cure beta thalassemia, a genetic blood disorder that results in the reduced production of hemoglobin, in adult mice.
Peptide nucleic acids are synthetic molecules that combine a synthetic protein backbone with the nucleobases found in DNA and RNA. The PNAs used in this study were created by Ly at Carnegie Mellon’s Center for Nucleic Acids Science and Technology (CNAST), a leading center for PNA science.
Their technique uses an FDA-approved nanoparticle to deliver PNA molecules paired with donor DNA to the site of a genetic mutation. When the PNA-DNA complex identifies a designated mutation, the PNA molecule binds to the DNA and unzips its two strands. The donor DNA binds with the faulty DNA and spurs the cell’s DNA repair pathways into action, allowing it to correct the error.
In the current study, the researchers used a technique similar to amniocentesis to inject the PNA complex into the amniotic fluid of pregnant mice whose fetuses carried a mutation in the beta-globin gene that causes beta thalassemia.
With just one injection of the PNA during gestation, the researchers were able to correct 6 percent of the mutations. This 6 percent correction was enough to cause dramatic improvements in the mice’s symptoms of beta thalassemia – and enough for the mice to be considered cured. Mice that were treated using PNA while in utero had levels of hemoglobin that were within the normal range, less spleen enlargement and increased survival rates.
The researchers also noted that there were no off-target effects from the treatment, a finding that might suggest this method would be preferable over other gene editing techniques like CRISPR/Cas9, which can erroneously damage off-target DNA.
“CRISPR is much easier to use, which makes it ideal for laboratory research. But the off-site errors make it less useful for therapeutics,” said Ly. “The PNA technique is more ideal for therapeutics. It doesn’t cut the DNA, it just binds to it and repairs things that seem unusual. We looked at 50 million samples and couldn’t find one offsite error when we used our PNA gene editing technique.”
The researchers believe that their technique might be able to achieve even higher success rates if they can administer it multiple times during gestation. They also hope to see if their technique can be applied to other conditions .
Learn more: Gene Editing Technique Cures Genetic Disorder in Utero
The Latest on: Curing a genetic condition in utero
[google_news title=”” keyword=”Curing a genetic condition in utero” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Curing a genetic condition in utero
- Two families, united by a rare disease, push for awareness and a cureon March 22, 2023 at 11:52 am
The two families have become close because daughters Lilly Gregg, 4, far left, and Blair Lorek, 5, far right, have the same rare genetic disease called hereditary spastic paraplegia. (Eric Lee) ...
- The most common genetic conditions in the worldon February 3, 2023 at 10:15 pm
Sometimes, though, there's simply nothing to be done to avoid certain conditions. For instance, hereditary, genetic ... While there is no cure for the condition, regular checkups with a physician ...
- Scientists set to cure genetic heart conditions within 'a few years'on July 29, 2022 at 2:48 am
Scientists have said they are just a few years away from curing genetic heart conditions that cause sudden death. These conditions affect around 260,000 people in the UK, so an international team ...
- Scientists set to cure genetic heart conditions that cause sudden deathon July 28, 2022 at 4:12 pm
Scientists have said they are just a few years away from curing genetic heart conditions which affect around 260,000 people in the UK and can cause sudden death. An international team of ...
- What is genetic disease research?on March 18, 2022 at 11:49 pm
There are over 7,000 rare genetic diseases with no cure. More than 300 million people are living with a genetic disease worldwide. And now staff, students, graduates and friends of the University are ...
- Genetic Fixes and Future Generationson November 21, 2021 at 3:29 pm
The goal of gene therapy is to cure disease or ailments by permanently repairing problems caused by flaws in our genes. For example, gene therapy could potentially be used to "fix" a genetic flaw ...
- Genetic Disorders in Manon April 28, 2018 at 8:30 am
This means that your genetic ... these disorders, with males typically being more severely affected than females. Some X-linked dominant conditions, are usually fatal in males either in utero ...
- "Genetic Report Cards" Will Be the Future of Predicting Disease Riskon February 28, 2018 at 4:04 am
From there, the prospect of curing incurable conditions seems closer than its ever been. The more such "direct-to-consumer" genetic testing ... they're still in the womb) — but the rest of ...
- New Prenatal Genetic Testing Could Predict Your Babyon August 2, 2016 at 2:20 pm
Beginning in the 1970s, amniocentesis allowed doctors to identify genetic disorders in utero, typically mid-pregnancy. Within the following decade, CVS provided an alternative to amniocentesis ...
- Experiments on Human Embryos Offer Little Hope for Curing Genetic Diseaseson February 4, 2016 at 2:36 am
Miller is right that curing genetic disease is a noble goal. All who aim to protect human life, including embryonic human life, should support it. But these new gene-editing technologies hold ...
via Bing News